Understanding Semaglutide and Its Mechanism of Action Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medications designed to regulate blood sugar levels and promote weight loss
If that lawsuit were to succeed, or if Novo Nordisks capacity to produce were to falter, the drugs may end up back on the shortage list
Patients often describe it as finally unlocking the last five percent helping them feel lighter tighter and more in control of cravings without the heavy or sluggish sensation associated with full therapeutic doses
Analysis of whole blood RNA-seq data in patients who had received albumin revealed specific upregulation of signatures related to B cells and neutrophils together with transcriptional changes in CD4+ T cells
Early evidence suggests that individuals using GLP-1s spend significantly less money at the grocery store, shifting their purchasing habits away from snacks, alcohol, and carbohydrates while also increasing demand for high-protein and nutrient-dense foods (e.g., Roe, 2025